Abstract
The field of tissue engineering and gene therapy has an exciting and promising future. During the past few years we have begun a comprehensive effort to investigate the use of myoblasts to improve and expand the treatment of stress urinary incontinence and bladder dysfunction. Moreover, we can expect the application of myoblast-mediated ex vivo gene transfer in the field of urology. In this paper we discuss the compositions of and methods involving the use of myogenic or muscle-derived cells for tissue engineering and cell-mediated gene therapy.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Yokoyama, T., Huard, J. & Chancellor, M. Myoblast therapy for stress urinary incontinence and bladder dysfunction. World J Urol 18, 56–61 (2000). https://doi.org/10.1007/s003450050010
Issue Date:
DOI: https://doi.org/10.1007/s003450050010